BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 4997558)

  • 1. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrauterine exchange transfusion in cases of iso-immunization].
    Zárate H; Bravo R; Avalos J; Pérez L; Torres B; Rodríguez Argüelles J
    Ginecol Obstet Mex; 1969 Aug; 26(154):221-34. PubMed ID: 4989177
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of the fetal blood group in amniotic flui. Preliminary note].
    Bellati U; Meroni P; Dambrosio F
    Minerva Ginecol; 1969 Sep; 21(18):1216-8. PubMed ID: 5408430
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spectrophotometric analysis of amniotic fluid prenatal diagnosis of fetal erythroblastosis].
    Radzuweit H; Eckert L; Zachäus V; Weigel W
    Zentralbl Gynakol; 1971 Mar; 93(12):380-7. PubMed ID: 4995302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in the diagnosis, therapy and prevention of morbus hemolyticum neonatorum].
    Kintzel HW
    Z Arztl Fortbild (Jena); 1968 Jun; 62(12):634-40. PubMed ID: 4971390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive care and prenatal therapy of hemolytic disease of newborn].
    Stamm H
    Ther Ggw; 1971 Nov; 110(11):1657-8 passim. PubMed ID: 5003495
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of different methods of amniotic fluid analysis in the diagnosis of Rh hemolytic disease (spectrophotometric and chemical determination of bilirubin, bilirubin-protein ratio, anti-Rho(D) titres).
    Dambrosio F; Della Torre L; Meroni P; Clerici-Bagozzi D
    Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):528-31. PubMed ID: 5001775
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Rh disease by ratios of bilirubin to albumin and hemopexin to albumin in amniotic fluid.
    Muller-Eberhard U; Bashore R
    N Engl J Med; 1970 May; 282(21):1163-7. PubMed ID: 4985821
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of anti-Rh antibodies in amniotic fluid].
    Benoit P; Gagnon M; Doray BH; Bonin A; Bertrand R
    Union Med Can; 1972 Jan; 101(1):58-64. PubMed ID: 4622396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Feto-maternal incompatibility in the Rh system. Hemolytic disease of the fetus].
    Merger R
    J Gynecol Obstet Biol Reprod (Paris); 1972 Mar; 1(2):105-6. PubMed ID: 4626033
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rh factor: anti-D isoimmunization and its therapeutic possibilities].
    Tucci G; Teofili MT
    Clin Ter; 1967 Dec; 43(6):567-89. PubMed ID: 4979582
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prenatal diagnostic and therapeutic possibilities in fetal erythroblastosis].
    Schellong G; Mast H
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):216-20. PubMed ID: 4975895
    [No Abstract]   [Full Text] [Related]  

  • 15. Amniocentesis and intrauterine transfusion in Rh-sensitized pregnancy.
    Little B; McCutcheon E; Desforges JF
    N Engl J Med; 1966 Feb; 274(6):332-5. PubMed ID: 4955259
    [No Abstract]   [Full Text] [Related]  

  • 16. Amniotic fluid evaluation after intrauterine transfusion.
    Mennuti MT; Branca P; Schwarz RH
    Obstet Gynecol; 1973 Dec; 42(6):823-6. PubMed ID: 4202168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of the blood group, Rh-D factor, and indirect Coombs' test using the amniotic fluid].
    Stipanić A; Crnić-Martinović M; Miculinić-Ivancić E; Bosner H; Vujaklija-Stipanović K
    Jugosl Ginekol Opstet; 1977; 17(5-6):377-80. PubMed ID: 108481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with the intraperitoneal fetal transfusion in severe hemolytic disease of the newborn].
    Maroni E; Schreiner WE
    Geburtshilfe Frauenheilkd; 1968 Jan; 28(1):26-41. PubMed ID: 4970142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.